Ladja, Sitti Mira .
HRN: 18-94-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
10/09/2023
10/15/2023
IV
60mg
OD
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes